BHATIA SANGEETA N. sold 7.6% of their position (400.00 shares) of VERTEX PHARMACEUTICALS INC / MA on the open market
Open‑market sale worth $202.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/5/2025ACC: 0000875320-25-000173
Director
Since Oct 2018
+396.00
Net shares
Net buyer
$202.3K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
796.00 acquired · 400.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+796.00
Price / share
—
Trade value
—
% of position
17.9%
5/1/2025
4.43K→5.23K
Common Stock
Direct
Shares
−400.00
Price / share
$505.86
Trade value
$202.34K
% of position
7.6%
5/2/2025
5.23K→4.83K
Total
Net shares
+396.00
Net value
-$202.34K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/1/2025 | A · Award | +796.00 | — | — | 17.9% | 4.43K | 5.23K |
| Common Stock Direct | 5/2/2025 | S · Sale | −400.00 | $505.86 | $202.34K | 7.6% | 5.23K | 4.83K |
| Total | +396.00 | -$202.34K | ||||||
Derivative Transactions0
No derivative transactions reported